Open AccessPrediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker
Author(s) -
Dennis Sgroi,
Erin Carney,
E Zarrella,
Lauren Steffel,
Shemeica Binns,
Dianne M. Finkelstein,
Jackie Szymonifka,
Atul K. Bhan,
Lois E. Shepherd,
Yi Zhang,
Catherine A. Schnabel,
Mark G. Erlander,
James N. Ingle,
Peggy L. Porter,
Hyman B. Muss,
K. Pritchard,
Dongsheng Tu,
David L. Rimm,
Paul E. Goss
Publication year - 2013
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/d42d-v946
Subject(s) - letrozole , biomarker , oncology , medicine , disease , computational biology , biology , cancer , genetics , breast cancer , tamoxifen